Cargando…
Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327215/ https://www.ncbi.nlm.nih.gov/pubmed/32612152 http://dx.doi.org/10.1038/s41423-020-0493-9 |
_version_ | 1783552497598595072 |
---|---|
author | Demaria, Olivier Carvelli, Julien Batista, Luciana Thibult, Marie-Laure Morel, Ariane André, Pascale Morel, Yannis Vély, Frederic Vivier, Eric |
author_facet | Demaria, Olivier Carvelli, Julien Batista, Luciana Thibult, Marie-Laure Morel, Ariane André, Pascale Morel, Yannis Vély, Frederic Vivier, Eric |
author_sort | Demaria, Olivier |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7327215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-73272152020-07-01 Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 Demaria, Olivier Carvelli, Julien Batista, Luciana Thibult, Marie-Laure Morel, Ariane André, Pascale Morel, Yannis Vély, Frederic Vivier, Eric Cell Mol Immunol Correspondence Nature Publishing Group UK 2020-07-01 2020-09 /pmc/articles/PMC7327215/ /pubmed/32612152 http://dx.doi.org/10.1038/s41423-020-0493-9 Text en © CSI and USTC 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Demaria, Olivier Carvelli, Julien Batista, Luciana Thibult, Marie-Laure Morel, Ariane André, Pascale Morel, Yannis Vély, Frederic Vivier, Eric Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 |
title | Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 |
title_full | Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 |
title_fullStr | Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 |
title_full_unstemmed | Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 |
title_short | Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 |
title_sort | identification of druggable inhibitory immune checkpoints on natural killer cells in covid-19 |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327215/ https://www.ncbi.nlm.nih.gov/pubmed/32612152 http://dx.doi.org/10.1038/s41423-020-0493-9 |
work_keys_str_mv | AT demariaolivier identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19 AT carvellijulien identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19 AT batistaluciana identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19 AT thibultmarielaure identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19 AT morelariane identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19 AT andrepascale identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19 AT morelyannis identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19 AT velyfrederic identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19 AT viviereric identificationofdruggableinhibitoryimmunecheckpointsonnaturalkillercellsincovid19 |